Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial Carcinoma.

Wataru FukuokayaTakahiro KimuraTakafumi YanagisawaShoji KimuraShunsuke TsuzukiYuhei KoikeYuya IwamotoYuki EneiMasatoshi TanakaFumihiko UrabeHajime OnumaMariko HondaJun MikiYu OyamaHirokazu AbeShin Egawa

Published in: Targeted oncology (2021)

Lifetime smoking exposure plays a significant role in the effectiveness of pembrolizumab in patients with metastatic UC.

Keyphrases

randomized controlled trial
smoking cessation
systematic review
advanced non small cell lung cancer